Combination and Targeted Therapies Accelerating Growth in the Global HER-2 Positive Breast Cancer Market: TechNavio Report
The key vendors in the Global HER-2 Positive Breast Cancer Market 2015-2019 are Celgene Corp., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Novartis AG and Sanofi SA London, 25 February 2015: TechNavio, an independent tech-focused global research firm, has announced the publication of its market research report on the Global HER-2 Positive Breast Cancer Market…
